Delivery Order SPE2DB20D3103-SPE2DB24FN5E8
- Not listed
- This federal contract award, valued at $10,667.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,561,853,439 units of the medication Carvedilol ER 40 mg capsules, with an ultimate completion date of August 18, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,363,779 units of the drug Carvedilol ER 40 mg in 30-count capsules. The $4,231.92 contract has an ultimate completion date of August 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, under which Amerisourcebergen...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) to supply 4,564,287,030 units of the medication Carvedilol ER 40 mg capsules. The contract is a Delivery Order with a Firm Fixed Price of $7,920.58 and a period of performance through April 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $60,280.47, is for the delivery of 4,567,956,736 units of the medication Carvedilol ER 40 mg capsules. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 18, 2025. This award is not designated as a set-aside contract, indicating open competition....
- This federal contract award, valued at $1,064.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Carvedilol ER 80 mg capsules. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of February 3, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Carvedilol ER 40 mg capsules, a medication used to treat certain heart conditions. The award is a Delivery Order with a Firm Fixed Price of $1,331.63 and an ultimate completion date of April 11, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (also known as AmerisourceBergen), a for-profit organization. The contract is for the delivery of 4,563,650,994 units of the pharmaceutical product Carvedilol ER 40 mg Capsule 30s. The contract is a firm fixed price delivery order with a potential value of $4,047.25 and a completion date of February 14, 2024. This award is not associated with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Carvedilol ER 40 mg capsules. The contract has a ceiling value of $4,369.30 and is structured as a firm fixed-price delivery order, with a period of performance ending on March 11, 2022. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $5,063.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of Carvedilol ER 40 mg capsules, a medication used to treat heart conditions. The contract is a firm fixed-price, non-set-aside arrangement with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide the Defense Logistics Agency (DLA) with 4,562,056,176 units of the cardiovascular medication Carvedilol ER 20 mg capsules. The $6,595.28 firm-fixed-price contract has a completion date of September 6, 2023. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN5E8Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The contract is for the delivery of 4,564,360,652 units of the medication Carvedilol ER 40 mg capsules in packages of 30. The award, valued at $4,925.38, is a delivery order with a firm fixed price and an ultimate completion date of April 23, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 4/22/24 |